MX9101778A - HARDENING AGENT FOR TISSUES AFFECTED BY THE DIGESTIVE SYSTEM. - Google Patents

HARDENING AGENT FOR TISSUES AFFECTED BY THE DIGESTIVE SYSTEM.

Info

Publication number
MX9101778A
MX9101778A MX9101778A MX9101778A MX9101778A MX 9101778 A MX9101778 A MX 9101778A MX 9101778 A MX9101778 A MX 9101778A MX 9101778 A MX9101778 A MX 9101778A MX 9101778 A MX9101778 A MX 9101778A
Authority
MX
Mexico
Prior art keywords
hardening agent
digestive system
tissues affected
tannic acid
aluminum
Prior art date
Application number
MX9101778A
Other languages
Spanish (es)
Inventor
Shi Zhao-Qi
Original Assignee
Traditional Cn Med Res Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03115319A external-priority patent/JP3133095B2/en
Application filed by Traditional Cn Med Res Lab Inc filed Critical Traditional Cn Med Res Lab Inc
Publication of MX9101778A publication Critical patent/MX9101778A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

El agente de endurecimiento contiene una composición compuesta de ácido tánico y sulfato de potasio aluminio en una proporción de ácido tánico a sulfato de potasio aluminio en una proporción de ácido tánico a sulfato de potasio-aluminio variando de 10 a 1 a 1 a 50 y un agente de estabilización extraído de drogas crudas de plantas que contienen un fenol, un flavonoide, catequina o un ácido policarboxílico.The hardening agent contains a composition composed of tannic acid and aluminum potassium sulfate in a ratio of tannic acid to aluminum potassium sulfate in a ratio of tannic acid to potassium aluminum sulfate ranging from 10 to 1 to 1 to 50 and a stabilizing agent extracted from crude drugs of plants that contain a phenol, a flavonoid, catechin or a polycarboxylic acid.

MX9101778A 1991-04-19 1991-10-25 HARDENING AGENT FOR TISSUES AFFECTED BY THE DIGESTIVE SYSTEM. MX9101778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03115319A JP3133095B2 (en) 1990-04-25 1991-04-19 Gastrointestinal sclerosis agent

Publications (1)

Publication Number Publication Date
MX9101778A true MX9101778A (en) 1994-05-31

Family

ID=14659653

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101778A MX9101778A (en) 1991-04-19 1991-10-25 HARDENING AGENT FOR TISSUES AFFECTED BY THE DIGESTIVE SYSTEM.

Country Status (4)

Country Link
KR (1) KR0183991B1 (en)
AU (1) AU653359B2 (en)
CA (1) CA2052532C (en)
MX (1) MX9101778A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332219T2 (en) * 1992-09-18 2003-01-09 Lequio Pharma Co Ltd INJECTION FOR HEALING INJURED ABNORMAL TISSUE, METHOD FOR THEIR PRODUCTION AND THEIR USE
KR100329256B1 (en) * 1993-11-17 2002-11-04 미츠비시 파마 코포레이션 Compositions for the treatment of lesion abnormal tissues, preparations thereof and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626433A (en) * 1985-05-20 1986-12-02 Preparation Gold, Inc. Remedy for hemorrhoids

Also Published As

Publication number Publication date
KR0183991B1 (en) 1999-05-01
AU8469691A (en) 1992-10-22
KR920019368A (en) 1992-11-19
AU653359B2 (en) 1994-09-29
CA2052532A1 (en) 1992-10-20
CA2052532C (en) 2004-01-20

Similar Documents

Publication Publication Date Title
MX9202407A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION.
CO4410203A1 (en) INSULIN ANALOG FORMULATIONS
CO5700796A2 (en) COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM USEFUL FOR INJECTIONS
ES2168334T3 (en) COMPOSITION FOR SKIN TREATMENT.
MX9308199A (en) ENZYME INHIBITORS.
PT100963A (en) PHARMACEUTICAL COMPOSITIONS FOR TOPIC APPLICATION OF HIGH PENETRATION THROUGH THE SKIN COMPREHENSING CERTAIN SPECIFIC NAO-IONIC POLYMERS
SV2004001556A (en) ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY
BR0108828A (en) Carbohydrate formulation (prebiotic adjuvant) for enhancing immune response
AR011846A1 (en) A PHARMACEUTICAL COMPOSITION, AND THE PROCEDURE TO PREPARE IT
ES2178048T3 (en) USE OF RIFAXIMINE AS A MEDICINAL PRODUCT FOR THE TREATMENT OF DIARRHEA BY CRYPTOSPORIDIOSIS.
ES2188582T3 (en) THE USE OF RANITIDINE-BISMUTE CITRATE IN COMBINATION WITH CLARITROMYCIN OR CLARITROMYCIN AND TETRACICLINE IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT GASTROINTESTINAL DISORDERS.
DE69114498T2 (en) SHORT-BED, SIMPLY UNSATURATED FATTY ACIDS, AND PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS.
NO975858L (en) Use of an extract of Cimicifuga racemosa
BR0112919A (en) Use of essential oils to combat gi tract infection by helicobacter-like organisms
AR003176A1 (en) A PHARMACEUTICAL COMPOSITION TO INHIBIT THE GROWTH OF CANCER
MX9401211A (en) COMPOSITION AND PROCEDURE TO COMBAT AGROMERATION OF FERTILIZERS.
BRPI0015939B8 (en) transdermal therapeutic system with improved stability and process for its preparation
MX9204031A (en) SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT.
BR0009524A (en) Use of a compound, and, pharmaceutical or veterinary composition
ES2188995T3 (en) USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS.
ES2152272T3 (en) USE OF SULODEXIDE AND MEDICINES CONTAINING IT FOR THE TREATMENT OF DIABETIC NEFROPATIA.
ES2080063T3 (en) SYNERGIC COMPOSITIONS CONTAINING IMAZALIL.
ES2105961B1 (en) PROCEDURE FOR THE PREPARATION AND PURIFICATION OF IODINE CONTRAST AGENTS.
BR9914834A (en) Bone pathobolism treatment agent, and, method to intensify the activity of osteoclastogenesis inhibiting factor
MX9101778A (en) HARDENING AGENT FOR TISSUES AFFECTED BY THE DIGESTIVE SYSTEM.